Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: people (1000), folks (1), individuals (699)

CH003 SOP regimen validation full

Description: Standard Operating Procedure Validation of Chemotherapy Protocols in ARIA (Wessex) (SOP:CH003) 1. Objective 1.1 The purpose of this standard
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH003-SOP-regimen-validation-full.pdf

Peptide receptor radionuclide therapy (PRRT) - patient information

Description: This factsheet explains what peptide receptor radionuclide therapy (PRRT) is, what the therapy involves, and what the possible benefits and risks
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Peptide-receptor-radionuclide-therapy-PRRT-3016-PIL.pdf

Liver enhanced recovery - patient information

Description: What to expect in the days before and after your liver resection operation and introducing our liver enhanced recovery programme (ERP
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Liver-enhanced-recovery-2257-PIL.pdf

Raised BMI in pregnancy - patient information

Description: Patient information factsheet Raised body mass index (BMI) in pregnancy, labour and birth Having a raised body mass index increases the
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Raised-BMI-in-pregnancy.pdf

HSCTMelphalan 200mg/m²

Description: Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT MELPHALAN (200mg/m2) Multiple Myeloma This regimen will only be available to prescribe at units which
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTMelphalan-200mg-m².pdf

Cetuximab (500)-Fluorouracil-Folinic Acid-Oxalplatin

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB(500)-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN Regimen This regimen may require funding • Colorectal Cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab500-Fluorouracil-FolinicAcid-Oxalplatin.pdf

Cetuximab (500)-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB(500)-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN Regimen This regimen may require funding • Colorectal Cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab500-Fluorouracil-FolinicAcid-Irinotecan.pdf

Capecitabine-Cetuximab-Oxaliplatin

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE-CETUXIMAB-OXALIPLATIN (21 day) This regimen may require funding Regimen • Colorectal Cancer – Capecitabine-Cetuximab-Oxaliplatin (21
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Cetuximab-Oxaliplatin.pdf

Wessex Diabetes Network - Individual health care plan - Injections

Description: Individual Health Care Plan � Educational Setting FOR PUPILS WITH DIABETES Name: DOB: School: Year Group: Date of Plan: Insert Photo here
Url: /Media/UHS-website-2019/Docs/Services/Child-health/Diabetes/Wessex-Diabetes-Network-Individual-health-care-plan-Injections.pdf

DOC CRF User Guidelines

Description: SCBR University Hospital Southampton NHS Foundation Trust GUIDELINES FOR USERS OF THE SOUTHAMPTON NIHR CLINICAL RESEARCH FACILITY (CRF) Welcome to the
Url: /Media/Southampton-Clinical-Research/BRC-CRF-templates/DOC-CRF-User-Guidelines.pdf

471 to 480 of 497

Previous … 46 47 48 49 50 Next